epocrates logo
epocrates logo
epocrates logo
  • 0

Herbs & Supplements

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Formulary
No Formulary Selected

close

 

Select a medication above to begin.

evening primrose seed oil

evening primrose oil (Oenothera biennis)

Sections:

  • Entire Monograph
  • Reported Uses
  • Reported Doses
  • Cautions
  • Drug Interactions
  • Adverse Reactions
  • Synonyms
  • Other Info
  • Add to Interaction Check

Reported Uses

  • NOTE: see Herb & Supplement Effectiveness Rating Definitions table
  • abortion [Insufficient Evidence]
  • acne [Insufficient Evidence]
  • ADHD [Insufficient Evidence]
  • Alzheimer disease [Insufficient Evidence]
  • asthma [Possibly Ineffective]
  • atopic dermatitis (eczema) [Insufficient Evidence]
  • biliary disorders [Insufficient Evidence]
  • chronic fatigue syndrome [Insufficient Evidence]
  • coronary heart disease [Insufficient Evidence]
  • developmental coordination disorder [Insufficient Evidence]
  • diabetic neuropathy [Insufficient Evidence]
  • dry eye disease [Insufficient Evidence]
  • dry skin [Insufficient Evidence]
  • dyslexia [Insufficient Evidence]
  • endometriosis [Insufficient Evidence]
  • gestational diabetes [Insufficient Evidence]
  • hepatitis B [Insufficient Evidence]
  • hyperlipidemia [Insufficient Evidence]
  • hysteroscopy [Insufficient Evidence]
  • IBS [Insufficient Evidence]
  • ichthyosis vulgaris [Insufficient Evidence]
  • infant development [Insufficient Evidence]
  • intermittent claudication [Insufficient Evidence]
  • liver CA [Insufficient Evidence]
  • mastalgia [Likely Ineffective]
  • menopausal symptoms [Insufficient Evidence]
  • molluscum contagiosum [Insufficient Evidence]
  • multiple sclerosis [Insufficient Evidence]
  • obesity [Insufficient Evidence]
  • osteopenia [Insufficient Evidence]
  • osteoporosis [Insufficient Evidence]
  • parturition [Insufficient Evidence]
  • peptic ulcer [Insufficient Evidence]
  • plaque psoriasis [Insufficient Evidence]
  • polycystic ovary syndrome [Insufficient Evidence]
  • postop pain [Insufficient Evidence]
  • pre-eclampsia [Insufficient Evidence]
  • premenstrual syndrome [Insufficient Evidence]
  • psoriatic arthritis [Insufficient Evidence]
  • Raynaud phenomenon [Insufficient Evidence]
  • rheumatoid arthritis [Insufficient Evidence]
  • schizophrenia [Insufficient Evidence]
  • Sjogren syndrome [Insufficient Evidence]
  • tardive dyskinesia [Insufficient Evidence]
  • ulcerative colitis [Insufficient Evidence]

Copyright © 2026. All Rights Reserved. Republication or redistribution, including by framing or similar means, is prohibited without the prior written consent of copyright holder.

Select a medication above to begin.

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information